The physiological expression of fetal isoforms may thus explain why a minor but significant reversal of MBNL mis-splicing was observed in DM1 NPCs following a near complete suppression of total DMPK mRNAs by the ASO treatment. The gene discussed is DMPK; the disease is myotonic dystrophy type 1.